It was suggested that SLC38A10 plays a vital role in the regulation of neurotransmission (Hellsten et al., 2017), and polymorphisms in SLC38A10 are associated with autism spectrum disorders (Celestino-Soper et al., 2011), bipolar disorder, schizophrenia, and Alzheimer disorder in human (Guan et al., 2019). This evidence concerns the gene SLC38A10 and bipolar disorder.